Substance / Medication

Prochlorperazine maleate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

63 trials linked to this intervention

63
Total Trials
5
Recruiting
21
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Prochlorperazine maleate versus placebo for the prophylaxis of acute mountain sickness: a double-blind randomized controlled trial.
Small Elan, Steins Harrison, Musi Martin et al. · J Travel Med · 2025
PMID: 40403745RCT
A case of carcinoid syndrome probably exacerbated by hemodialysis in which prochlorperazine maleate was effective.
Oda Keiko, Murata Tomohiro, Tsujimoto Kayo et al. · CEN Case Rep · 2024
PMID: 37606883Case ReportFull text (PMC)
Development of Floating Delivery for Solid Self Micro-Emulsifying Drug Delivery System of Prochlorperazine Maleate.
Jagdale Swati, Shinde Mayuri · Recent Pat Drug Deliv Formul · 2017
PMID: 29119940Other
Quantification of prochlorperazine maleate in human plasma by liquid chromatography-mass spectrometry: Application to a bioequivalence study.
Yan Miao, Zhu Yun-Gui, Li Huan-De et al. · J Chromatogr B Analyt Technol Biomed Life Sci · 2009
PMID: 19682959Other
Design of fast disintegrating tablets of prochlorperazine maleate by effervescence method.
Shirsand S B, Suresh Sarasija, Para M S et al. · Indian J Pharm Sci · 2009
PMID: 20502555OtherFull text (PMC)
Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability.
Badshah Amir, Subhan Fazal, Shah Nisar Hussain et al. · Drug Dev Ind Pharm · 2012
PMID: 21749268Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Prochlorperazine maleate (substance)
SNOMED CT
22827004
UMLS CUI
C0033231

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

6
Conditions
1
Biomarkers
2
Specialists
0
Symptoms
63
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Prochlorperazine maleate — Conditions, Biomarkers & Specialists | Healos | Healos